Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Suisse (CSUI) Cash & Equivalents (2016 - 2026)

Cannabis Suisse (CSUI) has disclosed Cash & Equivalents for 10 consecutive years, with $75.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 50.0% year-over-year to $75.0; the TTM value through Feb 2026 reached $75.0, up 50.0%, while the annual FY2025 figure was $2850.0, 90.02% down from the prior year.
  • Cash & Equivalents was $75.0 for Q1 2026 at Cannabis Suisse, down from $2625.0 in the prior quarter.
  • The five-year high for Cash & Equivalents was $38339.0 in Q4 2022, with the low at $44.0 in Q1 2024.
  • Historically, Cash & Equivalents has averaged $8203.4 across 5 years, with a median of $2737.5 in 2025.
  • Biggest YoY gain for Cash & Equivalents was 14252.76% in 2024; the steepest drop was 99.13% in 2024.
  • Over 5 years, Cash & Equivalents stood at $38339.0 in 2022, then tumbled by 85.8% to $5444.0 in 2023, then fell by 24.69% to $4100.0 in 2024, then tumbled by 35.98% to $2625.0 in 2025, then crashed by 97.14% to $75.0 in 2026.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $75.0 in Q1 2026, $2625.0 in Q4 2025, and $305.0 in Q3 2025.